MEMPHASYS LIMITED. — Capital/Financing Update 2019

Jul 4, 2019

Market Announcement

==> picture [33 x 50] intentionally omitted <==

5 July 2019

==> picture [451 x 5] intentionally omitted <==

Memphasys Limited (ASX: MEM) – Trading Halt

Description

The securities of Memphasys Limited (‘MEM’) will be placed in trading halt at the request of MEM, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Tuesday, 9 July 2019 or when the announcement is released to the market.

Issued by

Cheng Tang

Senior Adviser, Listings Compliance (Melbourne)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

5 July 2019 ASX Limited

==> picture [222 x 64] intentionally omitted <==

5 July 2019

Cheng Tang Senior Adviser, Listings Compliance (Melbourne) ASX Compliance Pty Limited Level 4 North Tower 525 Collins Street Melbourne Vic 3000

Sent by email - cheng.tang@asx.com.au

Dear Cheng,

REQUEST FOR TRADING HALT

Memphasys Limited (ASX Code: MEM) hereby requests a trading halt on its securities, effective from commencement of trading today and provides the following information in relation to ASX Listing Rule 17.1 -

• The Company is proposing an equity capital raising;

• The Company requests the trading halt to end on the earlier of the commencement of trading on Tuesday 9 July 2019, or when the completion of the equity capital raising announcement referred to above is released to the market;

• The Company is not aware of any reason why the trading halt should not be granted; and

• The Company is not aware of any other information that is necessary to inform the market about the trading halt.

If you have any queries, please do not hesitate to contact me.

Yours sincerely

Memphasys Limited Andrew Metcalfe Company Secretary

About Memphasys:

Memphasys Limited (ASX: MEM) specialises in biological separations for high value commercial applications. The Company’s patented membrane processes in combination with electrophoresis, the application of an electrical potential difference across a fluid, enable the separation of high value substances or contaminants from the fluid in which they are contained.

The main application of the technology is the separation of the most viable sperm cells for artificial reproduction, most particularly for human IVF.

Contact Details E info@memphasys.com P +612 8415 7300 W memphasys.com F +612 8415 7399 ABN 33 120 047 556

Memphasys Limited 30-32 Richmond Road Homebush West NSW 2140

Postal Address P.O. Box 2202 Homebush West NSW 2140